Thrombotic and thromboembolic complications of a new coronavirus infection COVID-19 a medical worker (a clinical case with an unfavorable outcome)

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The presented clinical case describes severe complications of a new coronavirus infection (COVID-19) in a comorbid patient with obliterating atherosclerosis of the arteries of the lower extremities, varicose veins of the lower extremities, hypertension, in the form of late thrombosis of the arteries of the lower extremities with the development of gangrene, which was the basis for amputation of the limb. The development, in the future, of complications such as: thromboembolism of the branches of the pulmonary artery and acute left ventricular failure, which caused a fatal outcome.

The principles and results of the medical examination conducted in order to establish a causal relationship of the disease with the professional activity of a medical worker are presented. The need for a multidisciplinary approach to the early diagnosis, prevention and treatment of COVID-19 and its complications, improving the mechanisms of admission to the professional activities of medical workers taking into account age and comorbid conditions in conditions of high risk of infection with SARS-CoV-2 is emphasized.

全文:

受限制的访问

作者简介

L. Strizhakov

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: s.a.babanov@mail.ru
ORCID iD: 0000-0002-2291-6453

Professor, MD

俄罗斯联邦, Moscow

S. Babanov

Samara State Medical University, Ministry of Health of Russia

Email: s.a.babanov@mail.ru
ORCID iD: 0000-0002-1667-737X

Professor, MD

俄罗斯联邦, Samara

T. Azovskova

Samara State Medical University, Ministry of Health of Russia

Email: s.a.babanov@mail.ru
ORCID iD: 0000-0002-0295-6888

Candidate of Medical Sciences

俄罗斯联邦, Samara

N. Lavrentyeva

Samara State Medical University, Ministry of Health of Russia

Email: s.a.babanov@mail.ru
ORCID iD: 0000-0002-7571-0328

Candidate of Medical Sciences

俄罗斯联邦, Samara

R. Baraeva

Regional Center of Occupational Pathology of Samara City Hospital Five

编辑信件的主要联系方式.
Email: s.a.babanov@mail.ru
ORCID iD: 0000-0002-4502-4140

Candidate of Medical Sciences

俄罗斯联邦, Samara

参考

  1. Косарев В.В., Бабанов С.А. Профессиональные заболевания медицинских работников. Самара: ООО «Офорт», 2014; 201 с. [Kosarev V.V., Babanov S.A. Professional'nye zabolevaniya meditsinskih rabotnikov. Samara: OOO «Ofort», 2014; 201 п. (in Russ.)].
  2. Бухтияров И.В. Эпидемиологические и клинико-экспертные проблемы профессиональной инфекционной заболеваемости работников при оказании медицинской помощи в условиях пандемии COVID-19. Медицина труда и промышленная экология. 2021; 61 (1): 4–12 [Bukhtiyarov I.V. Epidemiological, clinical, and expert problems of occupational infectious diseases of workers during medical care in the COVID-19 pandemic. Russian Journal of Occupational Health and Industrial Ecology. 2021; 61 (1): 4–12 (in Russ.)]. doi: 10.31089/1026-9428-2021-61-1-4-12
  3. Новая коронавирусная инфекция COVID-19: профессиональные аспекты сохранения здоровья и безопасности медицинских работников: методические рекомендации. Под ред. И.В. Бухтиярова, Ю.Ю. Горблянского. 2-е изд., перераб и доп. М.: АМТ, ФГБНУ НИИ МТ, 2022 [Novaya koronavirusnaya infektsiya COVID-19: professional'nye aspekty sokhraneniya zdorov'ya i bezopasnosti meditsinskikh rabotnikov: metodicheskie rekomendatsii. Pod red. I.V. Bukhtiyarova, Yu.Yu. Gorblyanskogo. 2-e izd., pererab i dop. M.: AMT, FGBNU NII MT, 2022 (in Russ.)].
  4. Гарипова Р.В., Стрижаков Л.А., Горблянский Ю.Ю. и др. Новая коронавирусная инфекция как профессиональное заболевание: сложные экспертные случаи. Медицина труда и промышленная экология. 2021; 61 (11): 720–5 [Garipova R.V., Strizhakov L.A., Gorblyansky Yu.Yu. et al. New coronavirus infection as an occupational disease: complex expert cases. Russian Journal of Occupational Health and Industrial Ecology. 2021; 61 (11): 720–5 (in Russ.)]. doi: 10.31089/1026-9428-2021-61-11-720-725
  5. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 15 (22.02.2022) [Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19)». Versiya 15 (22.02.2022) (in Russ.)].
  6. Li J., Gao J., Xu Y.P. et al. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial cells. Zhonghua Yi Xue Za Zhi. 2007; 87 (12): 833–7.
  7. Song W.-C., FitzGerald G.A. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. 2020; 130 (8): 3950–3. doi: 10.1172/JCI140183
  8. Nalugo M., Schulte L.J., Masood M.F., et al. Microvascular angiopathic consequences of COVID-19. Front Cardiovasc Med. 2021; 8: 636843. doi: 10.3389/fcvm.2021.636843
  9. Panigada M., Bottinol N., Tagliabue P. et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020; 18 (7): 1738–42. doi: 10.1111/jth.14850
  10. Klok F.A., Kruip M.J.H.A., Yander Meer N.J.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145–7. doi: 10.1016/j.thromres.2020.04.013
  11. Katsoularis I., Fonseca-Rodriquez O., Farrington P. et al. Risk of acute myocardial infarction and ischemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021; 398 (10300): 599–607. doi: 10.1016/S0140-6736(21)00896-5
  12. Преображенская И.С. COVID-19 и сердечно-сосудистая патология: обзор литературы. Поведенческая неврология. 2021; 2: 56–63 [Preobrazhenskaya I.S. COVID-19 and cardiovascular disease: literature review. Behavioral Neurology. 2021; 2: 56–63 (in Russ.)]. doi: 10.46393/2712-9675_2021_2_56_63
  13. Bonow R.O., O’Gara P.T., Yancy C.W. Cardiology and COVID-19. JAMA. 2020; 324 (12): 1131–2. doi: 10.1001/jama.2020.15088
  14. Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020; 8 (6): 46–7. doi: 10.1016/S2213-2600(20)30216-2
  15. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229): 1054–62. doi: 10.1016/S0140-6736(20)30566-3
  16. Guo T., Fan Y., Chen M. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 811–8. doi: 10.1001/jamacardio.2020.1017
  17. Рекомендации по ведению больных с коронавирусной инфекцией COVID-19 в острой фазе и при постковидном синдроме в амбулаторных условиях. Под ред. Воробьева П.А. Проблемы стандартизации в здравоохранении. 2021; 7-8: 3–96 [Recommendations for the management of patients with coronavirus infection COVID-19 in the acute phase and in postcovirus syndrome in outpatient settings. Ed. by Vorobyov P.A. Health Care Standardization Problems. 2021; 7-8: 3-96 (in Russ.)]. doi: 10.26347/1607-2502202107-08003-096
  18. Сафиуллина С.И., Литвинов Р.И. Рекомендации по профилактике и коррекции тромботических осложнений при COVID-19. Казанский медицинский журнал. 2020; 101 (4): 485–8 [Safiullina S.I., Litvinov R.I. Recommendations for the prevention and correction of thrombotic complications in COVID-19. Kazan Medical Journal. 2020; 101 (4): 485–8 (in Russ.)]. doi: 10.17816/KMJ2020-485
  19. Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020; 18 (4): 786–7. doi: 10.1111/jth.14781
  20. Christopher D.B., Hunter B.M., Michael B.Y. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18 (5): 1023–6. doi: 10.1111/jth.14810

补充文件

附件文件
动作
1. JATS XML
##common.cookie##